Effects of Dietary Acute Tryptophan Depletion (ATD) on NPY Serum Levels in Healthy Adult Humans Whilst Controlling for Methionine Supply-A Pilot Study

Nutrients
Janice W Y WongF D Zepf

Abstract

Central nervous serotonin (5-HT) can influence behaviour and neuropsychiatric disorders. Evidence from animal models suggest that lowered levels of neuropeptide Y (NPY) may have similar effects, although it is currently unknown whether decreased central nervous 5-HT impact NPY concentrations. Given that the production of NPY is dependent on the essential amino acid methionine (MET), it is imperative to account for the presence of MET in such investigations. Hence, this study sought to examine the effects of acute tryptophan depletion (ATD; a dietary procedure that temporarily lowers central nervous 5-HT synthesis) on serum concentrations of NPY, whilst using the potential renal acid load indicator (PRAL) to control for levels of MET. In a double-blind repeated measures design, 24 adult humans randomly received an AA-load lacking in TRP (ATD) on one occasion, and a balanced control mixture with TRP (BAL) on a second occasion, both with a PRAL of nearly 47.3 mEq of MET. Blood samples were obtained at 90, 180, and 240 min after each of the AA challenges. ATD, and therefore, diminished substrate availability for brain 5-HT synthesis did not lead to significant changes in serum NPY concentrations over time, compared to BAL, under an...Continue Reading

References

Jan 1, 1976·The American Journal of Physiology·W H Oldendorf, J Szabo
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S P KalraP S Kalra
Jan 1, 1989·Psychopharmacology·S N YoungP Finn
Nov 1, 1987·Journal of Neurochemistry·Q R SmithS I Rapoport
Dec 8, 1983·Nature·T E AdrianJ M Polak
Oct 1, 1983·Physiological Reviews·W M Pardridge
Jul 1, 1995·Journal of the American Dietetic Association·T Remer, F Manz
Sep 20, 1996·Neuroscience Letters·H HashimotoS Yamagami
Dec 26, 2001·Brain Research Bulletin·A G Ramage
Feb 15, 2002·European Journal of Nutrition·T Remer
Apr 30, 2003·The American Journal of Clinical Nutrition·Thomas RemerFriedrich Manz
Apr 3, 2004·Current Drug Targets·Jason C G HalfordTerence M Dovey
Dec 5, 2006·Autonomic Neuroscience : Basic & Clinical·Helen M Cox
Aug 30, 2007·Nature Neuroscience·Turhan Canli, Klaus-Peter Lesch
Feb 19, 2008·Journal of Affective Disorders·Christoph CzermakAlexander Neumeister
Oct 14, 2008·Medical Hypotheses·Florian Daniel ZepfMartin Holtmann
Nov 20, 2008·Journal of Neural Transmission·Florian Daniel ZepfF Poustka
Dec 16, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Amy D NguyenAmanda Sainsbury
Oct 15, 2011·Expert Opinion on Therapeutic Targets·Gang WuAleksander A Mathé
Apr 15, 2014·Frontiers in Neuroendocrinology·Debra A Bangasser, Rita J Valentino
Sep 15, 2014·Behavioural Brain Research·Jörg-Peter Voigt, Heidrun Fink
Nov 13, 2014·Hormone Molecular Biology and Clinical Investigation·Lori Asarian, Thomas Bächler
Dec 17, 2014·Neurobiology of Stress·Nicole M EnmanElisabeth J Van Bockstaele
Aug 8, 2015·The Lancet. Psychiatry·Marie SpiesSiegfried Kasper

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draw
pregnancy test

Software Mentioned

Excel
SPSS
SKIDPIT
Graph Pad Prism

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.